Tag: Guide

WFOE vs Joint Venture: Which Market Entry Structure for China? For foreign companies entering China, choosing between a Wholly Foreign-Owned Enterpris

SIAC vs CIETAC: Which Arbitration Body for China Commercial Disputes? body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif; line-height

CIETAC vs HKIAC: Which Arbitration Approach for China Commercial Disputes? body { font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif; line-h

How a Foreign Biotech Leveraged China's MAH System to Launch a Biosimilar in Shanghai In 2021, a mid-sized European biotech, BioVantis AG , became one

China Biotech Park Incentive Selector for Foreign Life Sciences Companies China has developed over 200 biomedical industry parks (生物医药产业园, Shēngwù Yīy

NMPA Drug Registration Timeline Estimator for Foreign Biotech in China Bringing a new drug to market in China requires navigating the National Medical